5-S-cysteinyldopa as diagnostic tumor marker for uveal malignant melanoma

Japanese Journal of Ophthalmology

Volumn 45, Issue 5, 2001, Pages 538-542

  Goto, Hiroshi ^a   Usui, Masahiko ^a   Wakamatsu, Kazumasa ^b   Ito, Shosuke ^b  

^a TOKYO MEDICAL UNIVERSITY   (Japan)

^b FUJITA HEALTH UNIVERSITY   (Japan)

Author keywords

5 S CD; Diagnosis; Tumor marker; Uveal melanoma

Indexed keywords

BIOCHEMICAL MARKER; CYSTEINYLDOPA;

ADULT; AGED; AQUEOUS HUMOR; ARTICLE; CANCER DIAGNOSIS; CATARACT; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DIAGNOSTIC APPROACH ROUTE; DIAGNOSTIC VALUE; DISEASE COURSE; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MALE; MELANOGENESIS; MELANOMA; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SKIN DISEASE; UVEA MELANOMA; VITREORETINOPATHY; VITREOUS BODY; VOLUNTEER;

ADULT; AGED; AGED, 80 AND OVER; AQUEOUS HUMOR; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DIHYDROXYPHENYLALANINE; FEMALE; HUMANS; MALE; MELANOMA; MIDDLE AGED; TUMOR MARKERS, BIOLOGICAL; UVEAL NEOPLASMS; VITREOUS BODY;

EID: 0034802577     PISSN: 00215155     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-5155(01)00393-8     Document Type: Article

References (22)

1. Incidence of uveal malignant melanoma in the resident population of Rochester and Olmsted Counties, Minnesota
2. Melanomas of the eye and other noncutaneous sites: Epidemiology aspects
3. Epidemiologic aspects of uveal melanoma
4. Incidence of malignant melanoma of the eye
5. Magnetic resonance imaging in the evaluation and differentiation of uveal melanoma
6. Problems in the diagnosis of malignant melanomas of the choroid and ciliary body. The 1972 Arthur J Bedell Lecture
7. Fine-needle aspiration biopsy of suspected intra-ocular tumors
8. Multilobed uveal melanoma masquerading as a postoperative choroidal detachment
9. Management of posterior uveal melanoma. Major review
10. Prognostic parameters in uveal melanoma: A review
11. 5-S-cysteinyldopa as a tumor marker for primary uveal malignant melanoma
12. Excretion of 5-S-cysteinyldopa in the urine of healthy subjects
13. Melanin-related metabolites as markers of melanoma: A review
14. Normal values of urinary excretion and serum concentration of 5-S-cysteinyldopa and 6-hydroxy-5-methoxyindole-2-carboxylic acid, biochemical markers of melanoma progression
15. Determination of DOPA, dopamine, and 5-S-cysteinyl-DOPA in plasma, urine, and tissue samples by high performance liquid chromatography with electrochemical detection
16. Improved HPLC determination of 5-S-cysteinyldopa in serum
17. Evaluation of tyrosinase mRNA as a tumor marker in the blood of melanoma patients
18. Detection of tyrosinase mRNA from the blood of melanoma patients
19. Detection of circulating melanoma cells by specific amplification of tyrosinase complementary DNA is not a reliable tumor marker in melanoma patients: A clinical two-center study
20. Recent advances in the chemistry of melanogenesis in mammals
21. Serum 5-S-cysteinyldopa (5-S-CD) as a marker of melanoma progression
22. Evaluation of melanin-related metabolites as markers of melanoma progression